BEVACIZUMAB, PEMBROLIZUMAB, VINORELBINE, GEMCITABINE, NIVOLUMAB, PEMETREXED, PACLITAXEL, CARBOPLATIN
IFCT-2502
Phase 2 small_molecule active
Quick answer
BEVACIZUMAB, PEMBROLIZUMAB, VINORELBINE, GEMCITABINE, NIVOLUMAB, PEMETREXED, PACLITAXEL, CARBOPLATIN for Non Small Cell Lung Cancer, Interstitial Lung Disease is a Phase 2 program (small_molecule) at CERO THERAPEUTICS HOLDINGS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CERO THERAPEUTICS HOLDINGS, INC.
- Indication
- Non Small Cell Lung Cancer, Interstitial Lung Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active